Literature DB >> 10801288

LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor.

M Nowak1, G C Gaines, J Rosenberg, R Minter, F R Bahjat, J Rectenwald, S L MacKay, C K Edwards, L L Moldawer.   

Abstract

Lipopolysaccharide and D-galactosamine induced lethality and apoptotic liver injury is dependent on endogenously produced tumor necrosis factor (TNF)-alpha. The present study was undertaken to determine whether membrane-associated or secreted TNF-alpha signaling through the p55 or p75 receptor was responsible for survival and hepatic injury after lipopolysaccharide administration in D-galactosamine-sensitized mice. Transgenic mice expressing null forms of TNF-alpha, the p55 and p75 receptor, and mice expressing only a cell-associated form of TNF-alpha were challenged with 8 mg D-galactosamine and 100 ng lipopolysaccharide. Mortality and apoptotic liver injury were only seen in wild-type and p75 knockout mice. p75 Knockout mice had significantly higher concentrations of plasma TNF-alpha than any other experimental group (P </= 0.05) and tended to have the highest mortality and liver injury. In contrast, p55 and TNF-alpha knockout mice and animals expressing only a cell-associated form of TNF-alpha exhibited no mortality or liver injury. We conclude that survival and apoptotic liver injury in response to lipopolysaccharide and D-galactosamine are dependent exclusively on secreted TNF-alpha signaling through the p55 receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801288     DOI: 10.1152/ajpregu.2000.278.5.R1202

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  55 in total

1.  Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure.

Authors:  Chuanlong Zhu; Yuwen Li; Wenting Li; Quan Wu; Rentao Gao
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

2.  Nuclear factor κB up-regulation of CCAAT/enhancer-binding protein β mediates hepatocyte resistance to tumor necrosis factor α toxicity.

Authors:  Yongjun Wang; Rajat Singh; Youqing Xiang; Linda E Greenbaum; Mark J Czaja
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

Review 3.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

4.  Role and Regulation of p65/β-Catenin Association During Liver Injury and Regeneration: A "Complex" Relationship.

Authors:  Kari Nejak-Bowen; Akshata Moghe; Pamela Cornuet; Morgan Preziosi; Shanmugam Nagarajan; Satdarshan P Monga
Journal:  Gene Expr       Date:  2017-04-28

5.  Protective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs.

Authors:  Sunil Tomar; Elizabeth E Zumbrun; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2015-03-06       Impact factor: 4.030

6.  Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure.

Authors:  Zhiwen Feng; Zhi Li; Deming Zhu; Wei Ling; Lei Zheng; Liyong Pu; Lianbao Kong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

8.  Preservation on calcium homeostasis is involved in mitochondrial protection of Limonium sinense against liver damage in mice.

Authors:  Xin-Hui Tang; Jin Chen; Xiao-Lan Yang; Li-Fang Yan; Jing Gao
Journal:  Pharmacogn Mag       Date:  2010-07       Impact factor: 1.085

9.  Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1β.

Authors:  Ghulam Ilyas; Enpeng Zhao; Kun Liu; Yu Lin; Lydia Tesfa; Kathryn E Tanaka; Mark J Czaja
Journal:  J Hepatol       Date:  2015-08-29       Impact factor: 25.083

Review 10.  Advances in alcoholic liver disease.

Authors:  Zhenyuan Song; Swati Joshi-Barve; Shrish Barve; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.